151 related articles for article (PubMed ID: 31589621)
21. Resazurin reduction assays for screening of anti-tubercular compounds against dormant and actively growing Mycobacterium tuberculosis, Mycobacterium bovis BCG and Mycobacterium smegmatis.
Taneja NK; Tyagi JS
J Antimicrob Chemother; 2007 Aug; 60(2):288-93. PubMed ID: 17586560
[TBL] [Abstract][Full Text] [Related]
22. A whole blood bactericidal assay for tuberculosis.
Wallis RS; Palaci M; Vinhas S; Hise AG; Ribeiro FC; Landen K; Cheon SH; Song HY; Phillips M; Dietze R; Ellner JJ
J Infect Dis; 2001 Apr; 183(8):1300-3. PubMed ID: 11262217
[TBL] [Abstract][Full Text] [Related]
23. The effect of growth rate on pyrazinamide activity in Mycobacterium tuberculosis - insights for early bactericidal activity?
Pullan ST; Allnutt JC; Devine R; Hatch KA; Jeeves RE; Hendon-Dunn CL; Marsh PD; Bacon J
BMC Infect Dis; 2016 May; 16():205. PubMed ID: 27184366
[TBL] [Abstract][Full Text] [Related]
24. Activities of drug combinations against Mycobacterium tuberculosis grown in aerobic and hypoxic acidic conditions.
Piccaro G; Giannoni F; Filippini P; Mustazzolu A; Fattorini L
Antimicrob Agents Chemother; 2013 Mar; 57(3):1428-33. PubMed ID: 23295931
[TBL] [Abstract][Full Text] [Related]
25. Pharmacophore modeling of pretomanid (PA-824) derivatives for antitubercular potency against replicating and non-replicating
Aher RB; Sarkar D
J Biomol Struct Dyn; 2021 Feb; 39(3):889-900. PubMed ID: 31983295
[TBL] [Abstract][Full Text] [Related]
26. A rapid drug susceptibility test for Mycobacterium tuberculosis using the hybridization protection assay.
Koga H; Miyamoto J; Ohno H; Ogawa K; Tomono K; Tashiro T; Kohno S
J Antimicrob Chemother; 1997 Aug; 40(2):189-94. PubMed ID: 9301983
[TBL] [Abstract][Full Text] [Related]
27. Low-oxygen-recovery assay for high-throughput screening of compounds against nonreplicating Mycobacterium tuberculosis.
Cho SH; Warit S; Wan B; Hwang CH; Pauli GF; Franzblau SG
Antimicrob Agents Chemother; 2007 Apr; 51(4):1380-5. PubMed ID: 17210775
[TBL] [Abstract][Full Text] [Related]
28. Rapid assessment of drug susceptibilities of Mycobacterium tuberculosis by means of luciferase reporter phages.
Jacobs WR; Barletta RG; Udani R; Chan J; Kalkut G; Sosne G; Kieser T; Sarkis GJ; Hatfull GF; Bloom BR
Science; 1993 May; 260(5109):819-22. PubMed ID: 8484123
[TBL] [Abstract][Full Text] [Related]
29. Bactericidal Disruption of Magnesium Metallostasis in Mycobacterium tuberculosis Is Counteracted by Mutations in the Metal Ion Transporter CorA.
Lopez Quezada L; Silve S; Kelinske M; Liba A; Diaz Gonzalez C; Kotev M; Goullieux L; Sans S; Roubert C; Lagrange S; Bacqué E; Couturier C; Pellet A; Blanc I; Ferron M; Debu F; Li K; Aubé J; Roberts J; Little D; Ling Y; Zhang J; Gold B; Nathan C
mBio; 2019 Jul; 10(4):. PubMed ID: 31289182
[TBL] [Abstract][Full Text] [Related]
30. Biological evaluation of novel substituted chloroquinolines targeting mycobacterial ATP synthase.
Khan SR; Singh S; Roy KK; Akhtar MS; Saxena AK; Krishnan MY
Int J Antimicrob Agents; 2013 Jan; 41(1):41-6. PubMed ID: 23141113
[TBL] [Abstract][Full Text] [Related]
31. A Novel Small-Molecule Inhibitor of the
Sukheja P; Kumar P; Mittal N; Li SG; Singleton E; Russo R; Perryman AL; Shrestha R; Awasthi D; Husain S; Soteropoulos P; Brukh R; Connell N; Freundlich JS; Alland D
mBio; 2017 Feb; 8(1):. PubMed ID: 28196957
[TBL] [Abstract][Full Text] [Related]
32. Application of Continuous Culture for Assessing Antibiotic Activity Against Mycobacterium tuberculosis.
Hendon-Dunn CL; Anwar S; Burton C; Bacon J
Methods Mol Biol; 2018; 1736():59-73. PubMed ID: 29322459
[TBL] [Abstract][Full Text] [Related]
33. Novel MenA Inhibitors Are Bactericidal against
Berube BJ; Russell D; Castro L; Choi SR; Narayanasamy P; Parish T
Antimicrob Agents Chemother; 2019 Jun; 63(6):. PubMed ID: 30962346
[No Abstract] [Full Text] [Related]
34. Effects of low incubation temperatures on the bactericidal activity of anti-tuberculosis drugs.
Coleman D; Waddell SJ; Mitchison DA
J Antimicrob Chemother; 2011 Jan; 66(1):146-50. PubMed ID: 21071459
[TBL] [Abstract][Full Text] [Related]
35. In vitro evaluation of dinactin, a potent microbial metabolite against Mycobacterium tuberculosis.
Hussain A; Rather MA; Bhat ZS; Majeed A; Maqbool M; Shah AM; Aga MA; Shah A; Mushtaq S; Sangwan PL; Hassan QP; Ahmad Z
Int J Antimicrob Agents; 2019 Jan; 53(1):49-53. PubMed ID: 30267759
[TBL] [Abstract][Full Text] [Related]
36. Synthesis and antitubercular activity of 7-chloro-4-quinolinylhydrazones derivatives.
Candéa AL; Ferreira Mde L; Pais KC; Cardoso LN; Kaiser CR; Henriques Md; Lourenço MC; Bezerra FA; de Souza MV
Bioorg Med Chem Lett; 2009 Nov; 19(22):6272-4. PubMed ID: 19819134
[TBL] [Abstract][Full Text] [Related]
37. In vitro activities of fourteen antimicrobial agents against drug susceptible and resistant clinical isolates of Mycobacterium tuberculosis and comparative intracellular activities against the virulent H37Rv strain in human macrophages.
Rastogi N; Labrousse V; Goh KS
Curr Microbiol; 1996 Sep; 33(3):167-75. PubMed ID: 8672093
[TBL] [Abstract][Full Text] [Related]
38. Bactericidal action of pulsed exposure to rifampicin, ethambutol, isoniazid & pyrazinamide on Mycobacterium tuberculosis in vitro.
Paramasivan CN; Herbert D; Prabhakar R
Indian J Med Res; 1993 Jul; 97():145-50. PubMed ID: 8406638
[TBL] [Abstract][Full Text] [Related]
39. Fast detection of drug interaction in Mycobacterium tuberculosis by a checkerboard resazurin method.
Caleffi-Ferracioli KR; Maltempe FG; Siqueira VL; Cardoso RF
Tuberculosis (Edinb); 2013 Nov; 93(6):660-3. PubMed ID: 24083948
[TBL] [Abstract][Full Text] [Related]
40. Ion Channel Blockers as Antimicrobial Agents, Efflux Inhibitors, and Enhancers of Macrophage Killing Activity against Drug Resistant Mycobacterium tuberculosis.
Machado D; Pires D; Perdigão J; Couto I; Portugal I; Martins M; Amaral L; Anes E; Viveiros M
PLoS One; 2016; 11(2):e0149326. PubMed ID: 26919135
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
